Association of Kidney Graft Long-term Outcome With Recipient Cystathionine Gamma-lyase Polymorphisms and Hydrogen Sulfide Levels: A Cohort Study
Authors:
- Matthieu HalfonMHMatthieu Halfon
- Thomas AgiusTAThomas Agius
- Sébastien DégliseSDSébastien Déglise
- Manuel PascualMPManuel Pascual
- Korkut UygunKUKorkut Uygun
- Heidi YehHYHeidi Yeh
- Leonardo V. RiellaLRLeonardo V. Riella
- James F. MarkmannJMJames F. Markmann
- Pierre-Yves BochudPBPierre-Yves Bochud
- Dela GolshayanDGDela Golshayan
Open Access
- 17 April 2025
- journal article
- kidney transplantation
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (5) , e1779
Abstract
Background.: Hydrogen sulfide (H2S) produced endogenously by the CTH gene-encoded cystathionine gamma-lyase protects from renal ischemia–reperfusion injury in preclinical models. Here, we hypothesized that CTH gene polymorphisms (single nucleotide polymorphism [SNP]) and recipient H2S serum levels influence kidney graft outcomes after transplantation. Methods.: We included all consecutive recipients of a first kidney transplant in the Swiss Transplant Cohort Study and with available genotyping. In addition, 192 deceased-donor kidney transplant recipients were randomly selected to measure baseline serum H2S levels. The primary endpoint was graft loss during follow-up. Results.: CTH SNPs were identified in up to 50% of the patients. During median follow-up (6.4 y, interquartile range: 3.9–9.8), graft loss was observed in 247 (9.8%) of 2518 patients. The incidence of graft loss was associated with the presence or absence of CTH SNPs. Specifically, rs672203 and rs10458561, increased the risk of graft loss (hazard ratio [HR]: 1.36, 95% confidence interval [CI]: 1.04-1.78, P = 0.02; and HR: 1.29, 95% CI: 1.0-1.66, P = 0.05; respectively), whereas rs113285275 was protective (HR: 0.78, 95% CI: 0.6-1.01, P = 0.05). Interestingly, rs672203 was associated with an increased risk of acute rejection (P = 0.05), whereas rs113285275 was associated with a lower risk of acute rejection (P = 0.01). Finally, in patients with delayed graft function, serum H2S levels correlated with lower graft dysfunction (defined as estimated glomerular filtration rate 2) (P = 0.05). Conclusions.: Graft outcome after kidney transplantation was associated with CTH genotype and, to some extent, H2S serum levels. Further research is needed to define the underlying protective mechanisms.Keywords
This publication has 44 references indexed in Scilit:
- Sodium thiosulfate acts as a hydrogen sulfide mimetic to prevent intimal hyperplasia via inhibition of tubulin polymerisationEBioMedicine, 2022
- Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery StenosisEuropean Journal of Vascular and Endovascular Surgery, 2022
- Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular AgingCell, 2018
- Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S ProductionCell, 2018
- Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide ProductionCell Metabolism, 2017
- Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritisKidney International, 2016
- Endogenous Hydrogen Sulfide Production Is Essential for Dietary Restriction BenefitsCell, 2015
- Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohortEuropean Journal of Epidemiology, 2013
- Hydrogen sulphide ameliorates ischaemia–reperfusion injury in an experimental model of non-heart-beating donor kidney transplantationBritish Journal of Surgery, 2010
- Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)Human Genetics, 2003